Navigation Links
Ustekinumab (CNTO 1275) Phase 3 Data Show Long-Term Improvement Of Chronic Plaque Psoriasis
Date:2/2/2008

New Findings from a Second Pivotal Phase 3 Study Show Subjects Receiving Infrequently Administered Ustekinumab Maintained Improvement from Psoriasis

Through One Year

SAN ANTONIO, Feb. 2 /PRNewswire/ -- One-year data from a second double-blind, placebo-controlled Phase 3 study showed therapy with ustekinumab given every 12 weeks provided sustained, clinically meaningful improvement in the treatment of moderate to severe plaque psoriasis through one year. According to findings presented at the Annual Meeting of the American Academy of Dermatology, 87 percent of patients responding to ustekinumab 45 mg maintenance therapy and 91 percent of patients responding to ustekinumab 90 mg maintenance therapy sustained at least a 75 percent improvement in psoriasis through one year, as measured by the Psoriasis Area and Severity Index (PASI 75). Ustekinumab is a new human monoclonal antibody with a novel mechanism of action that targets the cytokines interleukin-12 (IL-12) and interleukin-23 (IL-23), naturally occurring proteins that are important in the body's regulation of immune responses and that are also believed to play a role in immune-mediated inflammatory disorders, including psoriasis.

In December 2007, Centocor announced that a Biologics License Application (BLA) had been submitted to the U.S. Food and Drug Administration (FDA) and Janssen-Cilag International NV announced its submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMEA).

"These findings show that ustekinumab may control plaque psoriasis with as few as four injections a year," says lead study investigator Kenneth Gordon, MD, associate professor, Feinberg School of Medicine, Northwestern University, and Head of Dermatology, Evanston Northwestern Healthcare, Skokie, IL. "We are encouraged by the results seen in clinical trials to date and the hope that ustekinumab may hold for patients and the dermatology commun
'/>"/>

SOURCE Centocor, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Centocor and Janssen-Cilag Submit Applications Requesting Approval of Ustekinumab in the U.S. and Europe for Treatment of Moderate to Severe Plaque Psoriasis
2. Promising Phase 3 Trial Results Show Novel Biologic Therapy Ustekinumab (CNTO 1275) Significantly Improved Psoriasis
3. Pivotal Ustekinumab (CNTO 1275) Phase 3 Data to Debut at World Congress of Dermatology Meeting
4. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
5. Tigris Pharmaceuticals Initiates Phase I Study of AFP-464 in Patients with Solid Tumors
6. Nuvelo Initiates Phase 1 Clinical Trial of Thrombin Inhibitor, NU172
7. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
8. Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer
9. Inverseon Announces Positive Phase IIa Asthma Study
10. Catalyst Pharmaceutical Partners Begins Enrollment for Its U.S. Phase II Clinical Trial of CPP-109 in Patients with Cocaine Addiction
11. Takeda Doses First Patient in a U.S. Phase 1 Study of Hematide(TM) to Treat Chemotherapy Induced Anemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... 2015 A six-hour certification program on "How ... the Cannabis World Congress & Business Exposition (CWCBExpo) ... .  Taking place on Wednesday, June 17 th ... at the leading event on the East Coast for the ... Clover Leaf University, the first cannabis university to be approved, ...
(Date:5/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hgs483/cardiovascular ) has ... "Cardiovascular Drug Delivery - Technologies, Markets and ... delivery to the cardiovascular system is different from ... and physiology of the vascular system; it supplies ... body. Drugs can be introduced into the vascular ...
(Date:5/29/2015)... Research and Markets ( ... "Surgical/Operating Microscopes Market by Application & End ... to their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... poised to reach $806.6 million by 2020 from ... 12.3% from 2015 to 2020. , ,Major factors ...
Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
... Masimo (NASDAQ: MASI ) announced today that ... (RRa™) was presented at the New York ... Meeting in New York City. The new ... outcomes and patient safety impact of Masimo,s unique Acoustic Respiration ...
... /PRNewswire-iReach/ -- Physicians, Capital Investments, LLC (PCI/the ... and medical investment solutions is pleased to announce ... to Dallas, TX. The new headquarters, centrally located ... Company,s real estate development, business development and administrative ...
Cached Medicine Technology:New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 2New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 3New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 4New Clinical Study Presented at the NYPGA Meeting Shows Respiration Rate Monitoring -- Considered the Fourth Primary Vital Sign -- Has Been Revolutionized With Masimo rainbow Acoustic Monitoring Technology 5Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 2Physicians' Capital Investments Announces Relocation of its Corporate Headquarters to Dallas, TX 3
(Date:5/30/2015)... The results of a 40+ year ... high potential to cause mesothelioma, regardless of the volume ... on the Surviving Mesothelioma website. , The study ... Lodz, Poland found that, among the 138 cases of ... 2012, all of them happened at plants that had, ...
(Date:5/30/2015)... CA (PRWEB) May 30, 2015 ProIntro Magnify ... unique designs and animations. Instantly add an elegant opening title ... choosing from a range of clean design layouts. ProIntro Magnify ... ProIntro Magnify is extremely easy to use. Simply drag a ... using the on-screen-controls and parameters in the Inspector window then ...
(Date:5/30/2015)... At 73 years old, Lynn Kendall ... which she attributes to a lifetime of being health-conscious. She ... the release of her new book titled “ Cook for ... for Health and Longevity” features a collection of recipes and ... food . It is designed to encourage a lifestyle of ...
(Date:5/30/2015)... May 30, 2015 San Luis ... she is offering a free analysis and consultation for ... coincides with Disability Awareness Month, which was created by ... across the United States such as Polk recognize the ... awareness about the possibility of disability, as well as ...
(Date:5/30/2015)... “ Milli the Snail ” was featured on ... look at the latest and coolest applications on the market ... AppWatch and technology expert, conducted the app review and shared ... and educates children. , Interactive mobile games for children have ... and games they are playing are doing much for their ...
Breaking Medicine News(10 mins):Health News:New Study Finds Close Link Between Crocidolite Asbestos and Deadly Mesothelioma, According to Surviving Mesothelioma 2Health News:Announcing the release of ProIntro Magnify from Pixel Film Studios. 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 2Health News:Lynn Kendall Shows How to ‘Cook for Health and Longevity’ 3Health News:San Luis Obispo Insurance Agent Susan Polk Offering Complementary Insurance Analysis In Honor Of Disability Awareness Month 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2
... CHICAGO --- Teresa Woodruff, the Thomas J. Watkins Professor ... of Medicine, received the prestigious Presidential Award for Excellence ... House from President Barack Obama Monday, Dec. 12. ... called the Women,s Health Science Program for High School ...
... , FRIDAY, Dec. 16 (HealthDay News) -- Men often ... a new study finds. In what should come as no ... a certain type of guy tends to think all women want ... the cues. The study included 96 male and 103 female ...
... Europe provide plentiful food in summer, finding enough to eat ... avoid the problem by hibernating but this survival strategy is ... of some bears, large mammals remain fully awake throughout the ... with the comparative scarcity of food. Red deer, for ...
... for cystic fibrosis produced sustained improvement in lung function ... study. Along with the treatment,s efficacy and good safety ... treatment may improve adherence with therapy in these patients. ... Pharmaxis Limited, 318 patients were randomized to treatment with ...
... with HIV, immediate antiretroviral therapy (ART) appears preferable to ... the Journal of Infectious Diseases and now ... HIV-1 infection remain unproven, the findings support growing evidence ... the Medical College of Wisconsin in Milwaukee, led a ...
... Dec. 15 (HealthDay News) -- Reusing pacemakers from dead ... study. It involved 53 heart patients in Mumbai, ... deceased American patients. The pacemakers were sterilized before they ... the pacemakers, all the patients were alive and doing ...
Cached Medicine News:Health News:Northwestern scientist gets mentoring award at White House 2Health News:Northwestern scientist gets mentoring award at White House 3Health News:Men Often Misread Women's Sexual Cues: Study 2Health News:Winter diets? The secret is to chill the extremities 2Health News:Winter diets? The secret is to chill the extremities 3Health News:Long-term inhaled dry powder mannitol improves lung function in CF 2Health News:Study suggests early ART in recently HIV-infected patients preferable to delayed treatment 2Health News:Donated Pacemakers From U.S. Safely Reused in India: Study 2
... fingertip ratchet disengagement allowing smooth, ratchet-free grasping. ... state-of-the-art quality in an instrument of extremely ... Low profile cutting tips allow access to ... instruments are available in just about every ...
... design provides fingertip ratchet disengagement allowing smooth, ... program offers state-of-the-art quality in an instrument ... and durability. Low profile cutting tips allow ... Series I instruments are available in just ...
... patented ratchet design provides fingertip ratchet disengagement ... I Instrument program offers state-of-the-art quality in ... maintaining strength and durability. Low profile cutting ... joint spaces. Series I instruments are available ...
... A broad selection of procedurally ... capability and allow easy access to ... a variety of approaches.,Loop Handled Graspers ... that holds tissue firmly without tearing ...
Medicine Products: